Effect of oral administration of a new calcium channel blocking agent, bepridil on antipyrine clearance in man.
D000284:Administration, Oral; D000368:Aged; D000983:Antipyrine / Q000097:blood / Q000493:pharmacokinetics*; D015764:Bepridil; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D011759:Pyrrolidines / Q000008:administration & dosage / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D011759:Pyrrolidines; D015764:Bepridil; D000983:Antipyrine